ストックスクリーナーアプリを入手
72.04
0.71%
0.49
前日終値:
$71.55
開ける：
$71.63
24時間の取引高:
1.03M
Relative Volume:
0.14
時価総額：
$91.34B
収益：
$386.46B
当期純損益:
$4.49B
株価収益率:
20.12
EPS:
3.58
ネットキャッシュフロー:
$4.78B
1週間 パフォーマンス:
+1.75%
1か月 パフォーマンス:
+18.71%
6か月 パフォーマンス:
+11.75%
1年 パフォーマンス:
+25.41%
1日の値動き範囲:
$71.57
$72.09
1週間の範囲:
$70.40
$72.30
52週間の値動き範囲:
$43.56
$72.51
Cvs Health Corp Stock (CVS) Company Profile
CVS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
72.02 | 90.32B | 386.46B | 4.49B | 4.78B | 3.58 |
|
UNH
Unitedhealth Group Inc
|
303.10 | 276.10B | 422.82B | 22.09B | 25.27B | 23.08 |
|
CI
Cigna Group
|
300.19 | 80.28B | 261.22B | 5.40B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
310.33 | 70.71B | 189.25B | 5.35B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
296.75 | 35.74B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-14 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | アップグレード | Edward Jones | Hold → Buy |
| 2024-12-03 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-11-18 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | アップグレード | Barclays | Equal Weight → Overweight |
| 2024-10-04 | アップグレード | TD Cowen | Hold → Buy |
| 2024-05-30 | 開始されました | Robert W. Baird | Neutral |
| 2024-05-07 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-05-02 | ダウングレード | UBS | Buy → Neutral |
| 2024-05-01 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | 開始されました | Barclays | Equal Weight |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2023-12-22 | 開始されました | HSBC Securities | Buy |
| 2023-09-19 | アップグレード | Evercore ISI | In-line → Outperform |
| 2023-09-12 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | ダウングレード | Edward Jones | Buy → Hold |
| 2023-05-26 | 開始されました | Piper Sandler | Overweight |
| 2023-04-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-01-03 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 再開されました | Morgan Stanley | Overweight |
| 2022-06-17 | 開始されました | Loop Capital | Buy |
| 2022-05-27 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-02-11 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | 開始されました | Goldman | Buy |
| 2021-12-01 | 開始されました | Seaport Research Partners | Buy |
| 2021-05-19 | 開始されました | Wells Fargo | Equal Weight |
| 2021-03-17 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-01-08 | アップグレード | Jefferies | Hold → Buy |
| 2020-09-17 | 開始されました | Piper Sandler | Overweight |
| 2020-07-01 | 開始されました | SVB Leerink | Mkt Perform |
| 2020-05-14 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | 再開されました | RBC Capital Mkts | Outperform |
| 2019-09-12 | 開始されました | Deutsche Bank | Buy |
| 2019-06-05 | アップグレード | Standpoint Research | Hold → Buy |
| 2019-04-29 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | 開始されました | Guggenheim | Buy |
| 2019-04-15 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2019-04-10 | 繰り返されました | BofA/Merrill | Buy |
| 2019-03-13 | 開始されました | Bernstein | Outperform |
| 2019-02-20 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | 開始されました | UBS | Buy |
| 2018-12-18 | 開始されました | Barclays | Overweight |
| 2018-11-29 | 再開されました | Goldman | Neutral |
| 2018-11-28 | 開始されました | Evercore ISI | Outperform |
| 2018-10-26 | 再開されました | Wolfe Research | Peer Perform |
| 2018-07-09 | アップグレード | Citigroup | Neutral → Buy |
| 2018-02-27 | 再開されました | BofA/Merrill | Buy |
| 2018-02-13 | 繰り返されました | Citigroup | Neutral |
すべてを表示
Cvs Health Corp (CVS) 最新ニュース
3 Spectacular Stocks You Can Buy Now and Hold Forever - The Motley Fool
CVS vs. ELV: Which Healthcare Titan Is the Stronger Investment Today? - Yahoo Finance
CVS Health Corporation $CVS Shares Sold by Synovus Financial Corp - MarketBeat
Is CVS Health Corporation a candidate for recovery playJuly 2025 Opening Moves & Weekly Momentum Stock Picks - Newser
CVS Health Corporation $CVS Shares Bought by Smartleaf Asset Management LLC - MarketBeat
Wellington Management Group LLP Buys 183,232 Shares of CVS Health Corporation $CVS - MarketBeat
CW Advisors LLC Has $13.20 Million Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Cresset Asset Management LLC Decreases Stake in CVS Health Corporation $CVS - MarketBeat
How high can CVS Health Corporation stock goJuly 2025 Price Swings & Community Trade Idea Sharing Platform - Newser
CVS Health Services' Q2 AOI Falls Despite Sales Gain: More Risk Ahead? - Barchart.com
Quantitative breakdown of CVS Health Corporation recent move2025 Risk Factors & AI Based Trade Execution Alerts - Newser
Thematics Asset Management Has $4.53 Million Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health stock rating reiterated at Overweight by Cantor Fitzgerald - Investing.com
CVS Health Corporation $CVS Shares Sold by APG Asset Management N.V. - MarketBeat
Haverford Trust Co Has $5.20 Million Stake in CVS Health Corporation $CVS - MarketBeat
Advanced analytics toolkit walkthrough for CVS Health Corporation2025 Performance Recap & Technical Pattern Alert System - Newser
Heritage Financial Services LLC Purchases Shares of 3,828 CVS Health Corporation $CVS - MarketBeat
CVS avoids covering twice-yearly injectable PrEP - Gay City News
Allstate Corp Grows Stake in CVS Health Corporation $CVS - MarketBeat
Top chart patterns to watch in CVS Health CorporationJuly 2025 EndofMonth & Low Drawdown Momentum Ideas - Newser
Market reaction to CVS Health Corporation’s recent newsWeekly Trade Recap & Daily Risk Controlled Trade Plans - Newser
Level Four Advisory Services LLC Boosts Stock Position in CVS Health Corporation $CVS - MarketBeat
Is CVS Health Corporation stock poised for growth2025 Top Decliners & Long-Term Safe Investment Plans - Newser
Northern Trust Corp Has $850.67 Million Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Acquired by Price T Rowe Associates Inc. MD - MarketBeat
Vestmark Advisory Solutions Inc. Makes New $290,000 Investment in CVS Health Corporation $CVS - MarketBeat
Is CVS Health Corporation showing signs of accumulationJuly 2025 Closing Moves & AI Forecasted Stock Moves - Newser
Has CVS Health Corporation formed a bullish divergenceJuly 2025 EndofMonth & Low Risk Entry Point Tips - Newser
Institutional investors control 87% of CVS Health Corporation (NYSE:CVS) and were rewarded last week after stock increased 3.9% - Yahoo Finance
CVS Health Corporation $CVS Stock Holdings Decreased by Ethic Inc. - MarketBeat
Price action breakdown for CVS Health Corporation2025 Top Gainers & Expert Curated Trade Setups - Newser
GILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo - Yahoo Finance
CVS Gains in Pharmacy & Consumer Wellness Despite Reimbursement Woes - Yahoo Finance
Zacks.com featured highlights StoneCo, CVS Health, Integer and USANA Health Sciences - Yahoo Finance
Forvis Mazars Wealth Advisors LLC Sells 3,946 Shares of CVS Health Corporation $CVS - MarketBeat
Gilead Falls as CVS Hasn’t Yet Added PrEP HIV Shot to Drug Plans - Bloomberg.com
Why Is Gilead Sciences Stock Falling Thursday?CVS Health (NYSE:CVS), Gilead Sciences (NASDAQ:GILD) - Benzinga
Exclusive-CVS holds off adding Gilead’s new HIV prevention shot to drug coverage lists By Reuters - Investing.com
CVS Caremark ordered to pay $290M after Medicare fraud scheme exposed by former Aetna whistleblower - Fox Business
CVS Settles UCLA Professor’s Drug Tool Trademark, Copyright Suit - Bloomberg Law News
CVS Health (NYSE:CVS) Upgraded by Baird R W to Strong-Buy Rating - MarketBeat
CVS not entitled to insurance coverage for opioid litigation costs, Delaware Supreme Court rules - Providence Business News
CVS unit must pay $290 million in drug whistleblower lawsuit, judge rules - Reuters
CVS Opioid Insurance Loss Hits Companies Fighting Nuisance Suits - Bloomberg Law News
CVS PBM Overbilling Judgment Trebled To $289M - Law360
CVS Unit Must Pay $290 Million in Drug Whistleblower Lawsuit, Judge Rules - U.S. News & World Report
CVS Caremark Ordered to Pay $290 Million in Drug Subsidy Suit - Bloomberg Law News
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
Delaware court: CVS, not insurers, must pay opioid litigation costs - The Business Journals
Is CVS Health Corporation forming a reversal patternProduct Launch & Weekly High Conviction Ideas - Newser
CVS Health completes $4 billion debt offering, sets stage for major capital investment program - The Business Journals
Cvs Health Corp (CVS) 財務データ
収益
当期純利益
現金流量
EPS
Cvs Health Corp (CVS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| SANSONE GUY P | Director |
Jun 05 '25 |
Buy |
63.70 |
1,570 |
100,009 |
12,007 |
| ROBBINS LARRY | Director |
May 02 '25 |
Sale |
67.86 |
2,276,068 |
154,444,758 |
9,670,731 |
| ROBBINS LARRY | Director |
May 05 '25 |
Sale |
67.41 |
1,323,932 |
89,249,945 |
8,346,799 |
| ROBBINS LARRY | Director |
May 06 '25 |
Sale |
66.67 |
150,000 |
10,000,710 |
8,196,799 |
| Shah Prem S | EVP and Group President |
Mar 17 '25 |
Option Exercise |
62.21 |
846 |
52,630 |
43,190 |
| Clark James David | SVP, Cont & Chief Acct Officer |
Mar 05 '25 |
Option Exercise |
62.21 |
7,513 |
467,384 |
15,907 |
| Clark James David | SVP, Cont & Chief Acct Officer |
Mar 05 '25 |
Sale |
66.35 |
7,513 |
498,488 |
8,394 |
0.05%
0.12%
大文字化:
|
ボリューム (24 時間):